Current concepts in human immunodeficiency virus infection and AIDS

Clinical and Diagnostic Laboratory Immunology

Volumn 6, Issue 3, 1999, Pages 295-305

  Schwartz, Stanley A ^a,b   Nair, Madhavan P N ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b BUFFALO GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOUBLE STRANDED DNA; NUCLEOSIDE ANALOG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BRAIN DISEASE; CACHEXIA; ENDEMIC DISEASE; FETOMATERNAL TRANSFUSION; HAIRY CELL LEUKEMIA; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN T CELL LEUKEMIA VIRUS 1; MULTIDRUG RESISTANCE; OPPORTUNISTIC INFECTION; PARAPLEGIA; PRIORITY JOURNAL; SHORT SURVEY; SPINAL CORD DISEASE;

EID: 0032963999     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/cdli.6.3.295-305.1999     Document Type: Short Survey

References (58)

1. Alkhatib, G., C. Combadiere, C. Broder, Y. Feng, P. E. Kennedy, P. M. Murphy, and E. A. Berger. 1996. CC CKR5: a RANTES, MIP-1a, MIP-b receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272: 1955-1958.
2. Anonymous. 1998. AIDS epidemic update. Joint United Nations programme on HIV/AIDS. Geneva, Switzerland.
3. Balter, M. 1997. How does HIV overcome the body's T cell bodyguards? Science 278:1399-1400.
4. Bartlett, G. 1997. Protease inhibitors, a new class of drugs against human immunodeficiency virus. Human herpesvirus-8 and hepatitis G, newly identified causes of human disease. The role of infectious agents in "noninfectious" disease. JAMA 277:1865-1866.
5. Beekmann, S. E., and D. K. Henderson. 1995. HIV infection in healthcare workers: risk for infection and methods of prevention. Semin. Dermatol. 14:212-218.
6. Benito, J. M., J. M. Zabay, J. Gil, M. Bermejo, A. Escudero, E. Sanchez, and E. Fernandez-Cruz. 1997. Quantitative alterations of the functionally distinct subsets of CD4 and CD8 T lymphocytes in asymptomatic HIV infection-changes in the expression of CD45RO, CD45RA, CD46, CD38, HLA-DR, and CD25 antigens. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 14:128-135.
7. Berger, E. A., R. W. Doms, E.-M. Feryo, et al. 1998. A new classification for HIV-1. Nature 391:240.
8. Black, R. F. 1996. Transmission of HIV-1 in the breast-feeding process. J. Am. Dietetic Assoc. 96:267-274.
9. Boudet, F., H. Lecoeur, and M. L. Gougeon. 1996. Apoptosis associated with ex vivo down-regulation of Bcl-2 and up-regulation of Fas in potential cytotoxic CD8+ T lymphocytes during HIV infection. J. Immunol. 156:2282-2293.
10. + cells is associated with previous severe primary HIV infection. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 10:107-114.
11. Carpenter, C. C., M. A. Fischl, S. M. Hammer, M. S. Hirsch, D. M. Jacobsen, D. A. Katzenstein, J. S. Montaner, et al. 1996. Antiretroviral therapy for HIV infection in 1996. Recommendations of an international panel. International AIDS Society-USA. JAMA 276:146-154.
12. Centers for Disease Control. 1992. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Morbid. Mortal. Weekly Rep. 41:961-962.
13. Centers for Disease Control and Prevention. 1998. Notifiable diseases/deaths in selected cities. Morbid. Mortal. Weekly Rep. 47:1101-1116.
14. Centers for Disease Control and Prevention. 1998. HIV/AIDS surveillance report, vol. 10, p. 1-40. Centers for Disease Control and Prevention, Atlanta, Ga.
15. Chaudry, M. N., and D. H. Shepp. 1997. Antiretroviral agents. Current usage. Dermatol. Clinics 15:319-329.
16. Chen, I. S., and I. D. Rosenblatt. 1991. Human T-cell leukemia virus type II, p. 21-33. In R. C. Gallo and G. Jay (ed.), The human retroviruses. Academic Press, San Diego, Calif.
17. Clerici, M., and G. M. Shearer. 1992. Th2 switch is a critical step in the etiology of HIV infection. Immunol. Today 14:107-111.
18. Cocchi, F., A. J. DeVico, A. Grazino-Demo, S. K. Arya, R. C. Gallo, and P. Lusso. 1995. Identification of RANTES, MIP-1α and MIP-β as the major HIV suppressive factors produced by CD8+ T cell. Science 270:1811-1815.
19. Cohn, J. 1997. Exploiting the HIV-chemokine nexus. Science 275:1261-1262.
20. Conlon, K., A. Lloyd, U. Chattopadhyay, N. Lukacs, S. Kunkel, T. Schall, D. Taub, C. Morimoto, J. Osborne, and J. Oppenheim. 1995. CD8+ and CD45RA+ human peripheral blood lymphocytes are potent sources of macrophage inflammatory protein 1 alpha, interleukin-8 and RANTES. Eur. J. Immunol. 25:751-756.
21. Dean, M., M. Carrington, C. Winkler, G. A. Huttley, M. W. Smith, et al. 1996. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR-5 structural gene. Science 273:1856-1862.
22. Doran, C. M. 1997. New approaches to using antiretroviral therapy for the management of HIV infection. Ann. Pharmacother. 31:228-236.
23. Esparaza, J., S. Osmanov, and W. L. Heyward. 1995. HIV preventive vaccines. Progress to date. Drugs 50:792-804.
24. Feingberg, M. B., and A. R. McLean. 1997. AIDS: decline and fall of immune surveillance? Curr. Biol. 7:R136-R140.
25. + T cell renewal in early HIV-I infection: effect of highly active antiretroviral therapy. Nat. Med. 4:794-801.
26. + T cell decline in vivo. Virology 219:87-95.
27. Fyfe, G. A., and H. C. Lane. 1996. Biologic response modifiers (interleukins and interferons), p. 493-511. In S. Gupta (ed.), Immunology of HIV infection. Plenum Press, New York, N.Y.
28. Gilmore, N. 1996. Blood and blood product safety, p. 287-301. In J. Mann and D. Tarantula (ed.) AIDS In the world. Oxford University Press, Oxford, United Kingdom.
29. Gouen, M. L., and L. Montagnier. 1993. Apoptosis in AIDS. Science 260: 1269-1270.
30. Haseltine, W. A., and F. Wong-Staal. 1988. The molecular biology of the AIDS virus. Sci. Am. 259:52-60.
31. + T cells. Clin. Exp. Immunol. 107:300-305.
32. Kimura, S. 1997. Virus-related neurological disorders complicating in compromised hosts. Nippon Rinsho Jpn. J. Clin. Med. 55:949-953.
33. Klatzman, D., E. Champagne, and E. Chamaret. 1984. T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature 312: 767-768.
34. Koito, A., L. Stamatatos, and C. Cheng-Mayer. 1995. Small amino acid sequence changes within the V2 domain can affect the function of a T-cell line-tropic human immunodeficiency virus type I envelop gp 120. Virology 206:878-884.
35. Kwong, P. B., R. Wyatt, J. Robinson, R. W. Sweet, J. Sordroski, and A. W. Hendrickson. 1998. Structure of an HIV-gp 120 envelop glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 393:648-657.
36. + cell counts despite persistently detectable HIV load. N. Engl. J. Med. 338:1074-1075.
37. Levy, J. A. 1996. Infection by human immunodeficiency virus - CD4 is not enough. N. Engl. J. Med. 335:1528-1530.
38. Liles, W. C., and W. C. Van Voorhis. 1995. Nomenclature and biologic significance of cytokines involved in inflammation and the host immune response. J. Infect. Dis. 172:1573-1580.
39. Mackenwicz, C., and J. A. Levy. 1992. CD8+ cell anti-HIV activity: nonlytic suppression of virus replication. AIDS Res. Hum. Retrovirus 8:1039-1050.
40. Markovitz, D. M. 1993. Infection with the human immunodeficiency virus type-2. Ann. Intern. Med. 118:211-218.
41. Mellors, J. W., C. R. Rinaldo, Jr., P. Gupta, R. M. White, J. A. Todd, and L. A. Kingsley. 1996. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 272:1167-1170.
42. 9/L or more. Effect on viral, opportunistic, and bacterial infections. The National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group. JAMA 268:483-488.
43. Muro-Cacho, C. A., G. Pantaleo, and A. S. Fauci. 1995. Analysis of apoptosis in lymph nodes of HIV-infected persons. Intensity of apoptosis correlates with the general state of activation of the lymphoid tissue and not with stage of disease or viral burden. J. Immunol. 154:5555-5566.
44. Pal, R., A. Garzino-Demo, P. D. Markham, J. Burns, M. Brown, R. C. Gallo, and A. L. Devico. 1997. Inhibition of HIV-I infection by the β-chemokine MDC. Science 278:695-698.
45. Pantaleo, G., C. Graziosi, and A. S. Fauci. 1993. The immunopathogenesis of human immunodeficiency virus infection. N. Engl. J. Med. 328:327-335.
46. Perelson, A. S., A. U. Neumann, M. Markowitz, J. M. Leonard, and D. D. Ho. 1996. HIV-1 dynamics in vivo: virion clearance rate, infected cell life span, and viral generation time. Science 271:1583-1586.
47. Perlmutter, B. L., and B. R. Harris. 1997. New recommendations for prophylaxis after HIV exposure. Am. Family Phys. 55:507-517.
48. Poeschla, Y. M., and F. Wong-Stall. 1994. Progress towards gene therapy of HIV infection. Gene Ther. 1:13-26. (Review.)
49. Ratner, L. 1996. Genetic organization of HIV, p. 3-22. In S. Gupta (ed.), Immunology of HIV Infection. Plenum Press, New York, N.Y.
50. Schmidtmayerova, H., B. Sherry, and M. Bukrinsky. 1996. Chemokines and HIV replication. Nature 382:767.
51. Schnittman, A. M., and A. S. Fauci. 1994. Human immunodeficiency virus and acquired immunodeficiency syndrome: an update. Adv. Intern. Med. 39:305-354.
52. Shioda, T., J. A. Levy, and C. Chang-Mayer. 1991. Macrophage and T cell-line tropisms of HIV-I are determined by specific regions of the envelop gp 120 gene. Nature 349:167-169.
53. Spector, S. A., R. D. Gelber, N. McGrath, D. Wara, and A. Barzilai. 1994. A controlled trial of intravenous immune globulin for the prevention of serious bacterial infections in children receiving zidovudine for advanced human immunodeficiency virus infection. N. Engl. J. Med. 331:1181-1187.
54. Spina, C. A., H. E. Prince, and D. D. Richman. 1997. Preferential replication of HIV-1 in the CD45RO memory cell subset of primary CD4 lymphocytes in vitro. J. Clin. Investig. 99:1774-1785.
55. Travers, K., S. Mboup, R. Marlink, A. Gueye-Nidaye, T. Siby, I. Thior, I. Traore, A. Dieng-Sarr, J. L. Sankale, C. Mullins, et al. 1995. Natural protection against HIV-1 infection provided by HIV-2. Science 268:1612-1615.
56. Van de Perre, P., P. Lepage, J. Homsy, and F. Davis. 1992. Mother-to-infant transmission of human immunodeficiency virus by breast milk: presumed innocent or presumed guilty? Clin. Infect. Dis. 15:502-507.
57. Winkler, C., W. Modi, M. O. Smith, et al. 1998. Genetic restriction of AIDS pathogenesis by an SOFI chemokine gene variant. Science 279:389-393.
58. Yap, P. L. 1994. Does intravenous immune globulin have a role in HIV-infected patients? Clin. Exp. Immunol. 1:59-67.